Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Woong Gil Choi

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Journal of Diabetes and Metabolic Disorders|June 19, 2020
Comparison between calcium channel blocker with angiotensin converting enzyme inhibitor or angiotensin II type 1 receptor blocker combination on the development of new-onset diabetes in hypertensive Korean patientsYong Hoon Kim, Ae-Young Her, Seung-Woon Rha, et al.
Clinical Pharmacology and Therapeutics|December 14, 2025
Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug-Eluting Stent ImplantationHyun Woong Park, Jae-Hwan Lee, Jin-Ok Jeong, et al.
Drug Design, Development and Therapy|May 21, 2026
Efficacy and Safety of Fimasartan/Indapamide Combination Therapy versus Fimasartan Monotherapy in Patients with Essential Hypertension Inadequately Responding to Fimasartan 30 mg (FINEDUO): A Randomized, Double-Blind, Multicenter, Phase III StudyJong-Chan Youn, So-Young Lee, Cheol Woong Yu, et al.
American Heart Journal|July 5, 2023
Efficacy and safety of cilostazol-based triple antiplatelet therapy compared with clopidogrel-based dual antiplatelet therapy in patients with acute ST-elevation myocardial infarction undergoing percutaneous coronary intervention: A multicenter, randomized, open-label, phase 4 trialSoohyung Park, Seung-Woon Rha, Byoung Geol Choi, et al.
Circulation. Cardiovascular Interventions|May 2, 2020
Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Analysis From the SMART-DATE Randomized TrialKi Hong Choi, Young Bin Song, Joo Myung Lee, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 12, 2021
Effects of Prolonged Dual Antiplatelet Therapy in ST-Segment Elevation vs. Non-ST-Segment Elevation Myocardial InfarctionJihoon Kim, Young Bin Song, Ju-Hyeon Oh, et al.
Trials|June 27, 2016
Study design and rationale of the 'Balloon-Expandable Cobalt Chromium SCUBA Stent versus Self-Expandable COMPLETE-SE Nitinol Stent for the Atherosclerotic ILIAC Arterial Disease (SENS-ILIAC Trial) Trial': study protocol for a randomized controlled trialWoong Gil Choi, Seung Woon Rha, Cheol Ung Choi, et al.
Lancet (London, England)|March 17, 2018
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trialJoo-Yong Hahn, Young Bin Song, Ju-Hyeon Oh, et al.
Heart and Vessels|July 2, 2024
Balloon-expandable cobalt chromium stent versus self-expandable nitinol stent for the Atherosclerotic Iliac Arterial Disease (SENS-ILIAC Trial) Trial: a randomized controlled trialWoong Gil Choi, Seung-Woon Rha, Byoung Geol Choi, et al.
Trials|September 12, 2014
Efficacy of two different self-expanding nitinol stents for atherosclerotic femoropopliteal arterial disease (SENS-FP trial): study protocol for a randomized controlled trialSang Ho Park, Seung Woon Rha, Cheol Ung Choi, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Journal of Diabetes and Metabolic Disorders|June 19, 2020
Comparison between calcium channel blocker with angiotensin converting enzyme inhibitor or angiotensin II type 1 receptor blocker combination on the development of new-onset diabetes in hypertensive Korean patientsYong Hoon Kim, Ae-Young Her, Seung-Woon Rha, et al.
Clinical Pharmacology and Therapeutics|December 14, 2025
Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug-Eluting Stent ImplantationHyun Woong Park, Jae-Hwan Lee, Jin-Ok Jeong, et al.
Drug Design, Development and Therapy|May 21, 2026
Efficacy and Safety of Fimasartan/Indapamide Combination Therapy versus Fimasartan Monotherapy in Patients with Essential Hypertension Inadequately Responding to Fimasartan 30 mg (FINEDUO): A Randomized, Double-Blind, Multicenter, Phase III StudyJong-Chan Youn, So-Young Lee, Cheol Woong Yu, et al.
American Heart Journal|July 5, 2023
Efficacy and safety of cilostazol-based triple antiplatelet therapy compared with clopidogrel-based dual antiplatelet therapy in patients with acute ST-elevation myocardial infarction undergoing percutaneous coronary intervention: A multicenter, randomized, open-label, phase 4 trialSoohyung Park, Seung-Woon Rha, Byoung Geol Choi, et al.
Circulation. Cardiovascular Interventions|May 2, 2020
Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Analysis From the SMART-DATE Randomized TrialKi Hong Choi, Young Bin Song, Joo Myung Lee, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 12, 2021
Effects of Prolonged Dual Antiplatelet Therapy in ST-Segment Elevation vs. Non-ST-Segment Elevation Myocardial InfarctionJihoon Kim, Young Bin Song, Ju-Hyeon Oh, et al.
Trials|June 27, 2016
Study design and rationale of the 'Balloon-Expandable Cobalt Chromium SCUBA Stent versus Self-Expandable COMPLETE-SE Nitinol Stent for the Atherosclerotic ILIAC Arterial Disease (SENS-ILIAC Trial) Trial': study protocol for a randomized controlled trialWoong Gil Choi, Seung Woon Rha, Cheol Ung Choi, et al.
Lancet (London, England)|March 17, 2018
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trialJoo-Yong Hahn, Young Bin Song, Ju-Hyeon Oh, et al.
Heart and Vessels|July 2, 2024
Balloon-expandable cobalt chromium stent versus self-expandable nitinol stent for the Atherosclerotic Iliac Arterial Disease (SENS-ILIAC Trial) Trial: a randomized controlled trialWoong Gil Choi, Seung-Woon Rha, Byoung Geol Choi, et al.
Trials|September 12, 2014
Efficacy of two different self-expanding nitinol stents for atherosclerotic femoropopliteal arterial disease (SENS-FP trial): study protocol for a randomized controlled trialSang Ho Park, Seung Woon Rha, Cheol Ung Choi, et al.
Pageof 7